Clinical Trials Logo
NCT number NCT03182920
Study type Interventional
Source Eli Lilly and Company
Contact There may be multiple sites in this clinical trial. 1-877-CTLILL
Phone 1-317-615-4559
Status Not yet recruiting
Phase Phase 1
Start date June 2017
Completion date August 2017

Clinical Trial Summary

The purpose of this study is to look at the amount of study drug that gets into the blood stream and how long it takes the body to get rid of it by comparing the results of healthy elderly participants to those of healthy young participants. The tolerability of the study drug will be evaluated. Information about any side effects that may occur will also be collected.

This study will last up to approximately 19 days, not including screening. This study requires either one (Group 2) or two (Group 1) stays at the clinic each of at least four days/three nights. Participants will return for a follow-up seven days after last dose of study drug. Screening is required within 28 days prior to Day 1.

This study is for research purposes only and is not intended to treat any medical condition.

Clinical Trial Description


Study Design

Related Conditions & MeSH terms

See also
Status Clinical Trial Phase
 Terminated NCT00001844 - Study of New Magnetic Resonance Methods N/A
 Completed NCT02235961 - Investigate Safety, Tolerability and Pharmacokinetics for Single Doses of NNC9204-0530 Alone and in Combination With Liraglutide in Overweight to Obese But Otherwise Healthy Male Subjects Phase 1
 Completed NCT00526916 - PET Imaging of Peripheral Benzodiazepine Receptors in Patients With Neurocysticercosis Using [C-11]PBR28 Phase 1
 Completed NCT00527579 - PET Imaging of Peripheral Benzodiazepine Receptors in Patients With Neurocysticercosis Using [F-18]FB Phase 1
 Recruiting NCT02509494 - Staged Phase 3 Study to Assess the Safety and Immunogenicity of Ebola Candidate Vaccines Ad26.ZEBOV and MVA-BN-Filo During Implementation of Stages 1 and 2 Phase 3
 Terminated NCT02555085 - Single Ascending Doses of BIIB063 in Healthy Volunteers Phase 1
 Completed NCT03125018 - Accuracy of SpO2 for Noninvasive Pulse Oximeter Sensor (LNCS ADTX) N/A
 Completed NCT03124901 - Accuracy of Noninvasive Pulse Oximeter Measurement of Hemoglobin for Rainbow DCI Sensor N/A
 Completed NCT00091533 - Neural Correlates of Observation of Tactile Stimulation in Healthy Subjects N/A
 Completed NCT00068926 - VRC 300: Screening of Healthy Volunteers for Clinical Trials of Investigational Vaccines to Prevent Infectious Diseases N/A
 Completed NCT02947139 - Drug-Drug Interaction Study Between DWC20155 / DWC20156 and DWC20161 in Healthy Volunteers Phase 1
 Completed NCT00538798 - PET Imaging of Brain mGluR5 Receptors Using [18F]SP203 Phase 1
 Completed NCT00097461 - Revising Employee Benefits for the Sake of Health N/A
 Completed NCT00001936 - Electrical Muscle Stimulation to Aid Swallowing in Dysphagia N/A
 Completed NCT00004556 - The Effects of Dextroamphetamine on Brain Function N/A
 Recruiting NCT03119909 - Cognitive Adaptation N/A
 Completed NCT03179345 - Simulated Driving Performance, Daytime Sedation and Cognition in Healthy Volunteers Taking Gralise, Neurontin or Lyrica Phase 4
 Completed NCT02911870 - A Thorough QTc Trial Evaluating the Effect of SNAC on Cardiac Repolarisation in Healthy Male Subjects Phase 1
 Completed NCT03056898 - Health Professional Dietary Habits and Blood Omega-3 Fatty Acid Concentrations N/A
 Completed NCT02543567 - A Study to Evaluate A Range of Dose Levels of Ad26.ZEBOV and MVA‐BN‐Filo in Healthy Adult Participants Phase 3